Genixpharma

Zoleron

Therapeutic Segment:
Bisphosphonates

Generic Name:
Zoledronic Acid

Description:
Zoleron contains zoledronic acid, a bisphosphonic acid which is an inhibitor of osteoclastic bone resorption.. Zoledronic acid is designated chemically as (1-Hydroxy-2-imidazol-1-yl-phosphonoethyl) phosphonic acid monohydrate. Zoledronic acid monohydrate is a white crystalline powder.

Indication:
Treatment and Prevention of Osteoporosis in Postmenopausal Women, Osteoporosis in Men (including Glucocorticoid-Induced Osteoporosis) and Paget’s Disease of Bone.

Formulation:

  • Infusion

Strength:

  • 5mg/100ml

Pack Size:

  • 1’s
Scroll to Top